Biodesix (BDSX) now expects full-year 2026 revenue of $101 million to $103 million, down from its previous guidance of $108 million to $114 million issued on Aug. 5.

Shares dropped 52%, with intraday trading volume at over 1.2 million, versus a daily average of about 105,000.

iRhythm Technologies (IRTC) raised its fiscal 2026 revenue guidance but missed analyst expectations, and Q3 sales were shy of market consensus late Thursday.

Shares sank 30% as intraday trading volume soared to over 3.9 million from a daily average of roughly 568,000.

Axon Enterprise (AXON) reported Q3 non-GAAP earnings and revenue late Thursday below analyst expectations.

Shares fell 16%, with intraday trading volume at over 3.7 million, versus a daily average of about 1.00 million.

Price: 9.56, Change: -10.28, Percent Change: -51.81